Covid: Why are UK cases so high? – BBC News

https://www.bbc.com/news/health-58954793

…Health leaders in England have called for Covid restrictions to be re-introduced ahead of winter, as cases rise.

Thanks to the vaccine, getting infected is now much less likely to land you in
hospital. But soaring cases – which are outstripping some European nations – are still proving a cause for concern…

Dozens Of Top Nuclear Scientists With “Highest Security Clearances” Being Fired From Los Alamos Lab After Vax Mandate

https://www.nationandstate.com/2021/10/19/dozens-of-top-nuclear-scientists-with-highest-security-clearances-being-fired-from-los-alamos-lab-after-vax-mandate/
Dozens Of Top Nuclear Scientists With “Highest Security Clearances” Being Fired From Los Alamos Lab After Vax Mandate A last Friday deadline for Los Alamos National Lab employees to get vaccinated has come and gone, with a judge on the same day denying a request by 114 employees there to block the nuclear lab’s vaccine mandate…

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs

https://www.who.int/news/item/11-08-2021-who-s-solidarity-clinical-trial-enters-a-new-phase-with-three-new-candidate-drugs

The World Health Organization (WHO) has announced the next phase in
its Solidarity trial: Solidarity PLUS will enroll hospitalized patients to test three new drugs in hospitalized COVID-19 patients.

These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized COVID-19 patients. They are already used for other
indications: artesunate is used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn’s Disease and rheumatoid arthritis.

These drugs were donated for the trial by their manufacturers.

The Solidarity PLUS trial is a
platform trial that represents the largest global collaboration among
WHO Member States. It involves thousands of researchers in over 600
hospitals in 52 countries, 16 more countries than the first phase of trials. This allows the trial to assess multiple treatments at the same
time using a single protocol, recruiting thousands of patients to generate robust estimates on the effect a drug may have on mortality–even moderate effects.

It also allows new treatments to be added and ineffective treatments to be dropped throughout the course of the trial.

Previously, four drugs were evaluated by the trial. The results showed that remdesivir, hydroxychloroquine, lopinavir and interferon
had little or no effect on hospitalized patients with COVID-19.

Delta Airlines CEO Announces Company Will Ditch COVID Vaccine Mandate – The Citizen Media

https://thecitizenmedia.com/2021/10/16/delta-airlines-ceo-announces-company-will-ditch-covid-vaccine-mandate/
Delta Airlines CEO Ed Bastian said that the company will be dropping its COVID-19 vaccine mandate, making it the only U.S. airline that will not require employees to receive their shots. Bastin said during a Thursday appearance on Fox Business’ “The Claman …

How many people get ‘long COVID?’ More than half, study. – Scientific Inquirer

https://scientificinquirer.com/2021/10/16/how-many-people-get-long-covid-more-than-half-researchers-find/

The researchers conducted a systematic review of 57 reports that included data from 250,351 unvaccinated adults and children who were diagnosed with COVID-19 from December 2019 through March 2021. Among those studied, 79% were hospitalized, and most patients (79%) lived in high-income countries. Patients’ median age was 54, and the majority of individuals (56%) were male.

The researchers analyzed patients’ health post-COVID during three intervals at one month (short-term), two to five months (intermediate-term) and six or more months (long-term).

According to the findings, survivors experienced an array of residual health issues associated with COVID-19. Generally, these complications affected a patient’s general well-being, their mobility or organ systems. Overall, one in two survivors experienced long-term COVID manifestations. The rates remained largely constant from one month through six or more months after their initial illness.

The investigators nconst…:

  • General well-being: …
  • Mobility: …
  • Neurologic concerns:
  • Mental health disorders:
  • Lung abnormalities: Six in ten survivors had chest imaging abnormality and more than a quarter of patients had difficulty breathing.
  • Cardiovascular issues: Chest pain and palpitations were among the commonly reported conditions.
  • Skin conditions: Nearly one in five patients experienced hair loss or rashes.
  • Digestive issues: Stomach pain, lack of appetite, diarrhea and vomiting were among the commonly reported conditions.

“… adverse health effects from COVID-19 can linger,” said co-lead investigator Vernon Chinchilli, chair of the Department of Public Health Sciences. “… this study examined a larger population, including people in high-, middle- and low-income countries, and examined many more symptoms. Therefore, we believe our findings are quite robust given the available data.”…

German state allows ALL businesses to ban unvaxxed customers, even for groceries & other essentials — RT World News

https://www.rt.com/news/537644-hesse-bans-unvaxxed-supermarkets/

16 Oct, 2021 02:15 / Updated 3 hours ago

The German state of Hesse has become the first to allow
businesses to deny the unvaccinated access even to basic necessities,
setting a troubling precedent as its neighbors wrestle with protests
against vaccination mandates.

Hessian supermarkets have
been granted permission to deny the unvaccinated the right to buy food
and other essentials, the state chancellery confirmed to German magazine
BILD on Friday. Under the new policy, stores can decide whether to
implement the ‘2G rule’, which means allowing entry only to the
vaccinated and recovered (‘geimpft’ and ‘genesen’ in German) or the more
lax ‘3G rule’, encompassing those who have tested negative for the
virus (getestet).



Also on rt.com
‘It’s about fairness’: Germany scraps Covid quarantine compensation for unvaccinated workers

Minister-President Volker Bouffier somewhat bafflingly told BILD
he hoped the new rule wouldn’t be widely implemented, explaining: “We
expect that this option will only be used on some days and that
businesses which cater to everyday needs will not make use of it.”

“The greatest protection is provided by vaccination. And still it is uncomplicated, unbureaucratic and free to get,” he boasted,
noting that masking and social distancing requirements would remain in
place for businesses that failed to adopt the more exclusionary 2G Rule.
In exchange for admitting only vaccinated or recovered people, 2G
businesses are allowed to forgo social distancing and mask mandates –
perhaps a tempting tradeoff after 18 months of burdensome face
coverings.

In addition to the new 2G option,
hospital staff who remain unvaccinated must be tested for Covid-19 twice
a week, and students are still required to mask up while seated in
class.

While at least eight other German states
have opened up the 2G option for certain businesses like bars,
restaurants, gyms, cinemas and brothels, Hesse is the first to allow the
rule at grocery stores and other retail shops.

Though
other European nations like Italy and France have implemented strict
vaccine requirements forbidding the unvaxxed from working (Italy) or
eating at cafes (France), most leaders have stopped short of directly
mandating jabs for their citizens. However, concerns about vaccine
passports have sent hundreds of thousands of people into the streets to
protest, even while countries like the US begin to reopen for travel –
to the vaccinated only, of course.


Also on rt.com
Hundreds blockade Italian ports as mandatory Covid-19 passes come into effect for all workers (VIDEOS)

JMSE | Free Full-Text | Exposure to Electromagnetic Fields (EMF) from Submarine Power Cables Can Trigger Strength-Dependent Behavioural and Physiological Responses in Edible Crab, Cancer pagurus (L.)

Comment by tonytran2015: What are the effects of these very low frequency EMF on mammals? Then what are the effect of EMF at extremely high frequencies (2 GHz and up) on human?

https://www.mdpi.com/2077-1312/9/7/776

The current study investigated the effects of different strength
Electromagnetic Field (EMF) exposure (250 µT, 500 µT, 1000 µT) on the
commercially important decapod, edible crab (Cancer pagurus, Linnaeus, 1758). Stress related parameters were measured (l-Lactate, d-Glucose,
Total Haemocyte Count (THC)) in addition to behavioural and response
parameters (shelter preference and time spent resting/roaming) over 24 h
periods. EMF strengths of 250 µT were found to have limited
physiological and behavioural impacts. Exposure to 500 µT and 1000 µT
were found to disrupt the l-Lactate and d-Glucose
circadian rhythm and alter THC. Crabs showed a clear attraction to EMF
exposed (500 µT and 1000 µT) shelters with a significant reduction in
time spent roaming. Consequently, EMF emitted from MREDs will likely
affect crabs in a strength-dependent manner thus highlighting the need
for reliable in-situ measurements. This information is essential for
policy making, environmental assessments, and in understanding the
impacts of increased anthropogenic EMF on marine organisms.

When breezy, wear masks outdoors to prevent coronavirus exposure – Scientific Inquirer

https://scientificinquirer.com/2021/10/15/when-breezy-wear-masks-outdoors-to-prevent-coronavirus-exposure/

WASHINGTON, October 12, 2021 — As the highly infectious delta variant of the coronavirus continues to spread across the United States, guidelines from the Centers for Disease Control and Prevention recommend even the vaccinated wear masks indoors to prevent exposure and transmission.

However, it is less clear what people should do when outside.

In Physics of Fluids, by AIP Publishing, researchers from the Indian Institute of Technology Bombay found when a person coughs outdoors, wind flowing in the same direction can propagate the virus faster over longer distances than in calm conditions.

“The study is significant in that it points to the increased infection risk that coughing in the same direction as the wind could bring about,” co-author Amit Agrawal said. “Based on the results, we recommend wearing masks outdoors, particularly in breezy conditions.”

Other guidelines,…

Vitamin D and Covid 19: Big Pharma’s worst nightmare – La Vie en Yoga

https://lavieenyoga.blog/2020/12/07/vitamin-d-and-covid-19-big-pharmas-worst-nightmare/

As far back as May, Joanne. E. Manson, Prof. of Medicine at Harvard Medical School described the evidence as being “quite compelling” that Vitamin D offers protection against infection and complications from Covid 19, ”particularly against the severe reaction cytokine storm.” Rose Anne Kenney, from Trinity College Dublin called the evidence, “very strong.” And in his letter to the British Medical Journal on October 5, Australian GP, Peter J. Lewis echoed these and other voices, when he referred to the evidence from research studies as “overwhelming”.

Large scale controlled clinical trials require serious funding, organization and human resources, which is why, especially when there is no drug company behind the intervention, they more often require governmental support. For the past several months, doctors, scientists and healthcare professionals have been calling for such trials to be conducted into Vitamin D and Covid-19 on the strength of the results of the numerous observational studies. This issue has been raised in several BMJ Rapid Responses and can be read in the conclusions of many of the researchers themselves, often in quite urgent terms.

Thankfully, (although apparently unbeknownst to the Health Secretary or the BBC) we now have two, albeit quite small, controlled clinical studies on Vitamin D and Vitamin D analogues in the treatment of Covid-19. The most recent was carried out in India and was published in Nature on 19 November 2020. This study concluded that Vitamin D deficiency not only markedly increases the chance of having severe disease after infection with SARS Cov-2, but that Vitamin D deficiency translates to increased mortality.

The first randomized clinical trial in the world on Vitamin D and Covid-19 was conducted at the Reina Sofía University Hospital in Spain and the results were published August 29 in The Journal of Steroid Biochemistry and Molecular Biology. The results were clear. Vitamin D supplementation improved outcomes for Covid-19 patients, reduced the chances for ending up in intensive care, and reduced mortality. The researchers are now extending the study throughout hospitals in Spain.

These two clinical studies support a number of the findings of the other 40 or so observational studies on Covid-19 and Vitamin D:

  • There is a greater incidence of Covid-19 in Vitamin D deficient patients and Vitamin D deficient people are more likely to test positive for the virus.
  • Covid-19 patients with low Vitamin D levels are more likely to be hospitalized.
  • Vitamin D supplementation reduces the likelihood of a Covid-19 patient going to intensive care.
  • Vitamin D offers a protective effect both in terms of symptoms and survival in those who take it as a regular supplement before contracting the virus.
  • Supplementing with Vitamin D, or exposure to UVB radiation that forms Vitamin D through the skin, reduces Covid-19 fatalities.
  • The most gains are experienced in patients who are more severely Vitamin D deficient.
  • Moderate doses are more effective than high doses.

You can read all the studies here with a helpful summary here.